Header
Header
Article

New patent expiration for Padagis Us drug EVAMIST – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for Padagis Us drug EVAMIST


Annual Drug Patent Expirations for EVAMIST

Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

EVAMIST drug price trends.

Drug patent litigation for EVAMIST.

This drug has seventeen patent family members in ten countries.

The generic ingredient in EVAMIST is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Padagis Us drug EVAMIST



Source link

Back to top button